English | Español
Patient Daily | Apr 26, 2023

U.S. Food and Drug Administration Issues Complete Response Letter for Mirikizumab
Patient Daily | Apr 26, 2023

RELIAS AND 321 COFFEE PARTNER TO OPEN INCLUSIVE CAFÉ AT RELIAS HEADQUARTERS
Patient Daily | Apr 26, 2023

Introducing Navina Mini – a Small Solution for Instant Results
Patient Daily | Apr 26, 2023

InterVenn Biosciences to Present Clinical Data on Circulating Serum Glycoproteins for Unprecedented Pre-Cancer Detection as “Poster of Distinction” at Digestive Disease Week 2023
Patient Daily | Apr 26, 2023

Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
Patient Daily | Apr 26, 2023

Sotera Health Announces First-Quarter 2023 Earnings Release Date
Sam Jackson | Apr 25, 2023

NICO Corporation announces 'revolutionary' results from trial for hemorrhagic stroke treatment
Sam Jackson | Apr 25, 2023

Teriflunomide study shows promise in delaying first symptoms of MS using medication as an 'early intervention'

Trending
Patient Daily | Jul 15, 2025

Scottsdale Sinus & Allergy Center garners 500+ Google reviews with a 4.9-star rating
Patient Daily | Jul 11, 2025

Physician assistant on headaches and sinusitis: ‘Sinus headaches are known to trigger your migraines’
Patient Daily | Jul 15, 2025

Gulf Coast Breathe Free Sinus & Allergy Centers earns 250+ Google reviews with a 4.9-star rating
+ Pharmaceuticals
Patient Daily | Jul 10, 2025

PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'